We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Dermatology

Saturated Saline Immersion: A Novel and Noninvasive Approach for Refractory Plantar Warts

MedXY Editorial Team•Mar 5, 2026•Dermatology
dermatologyHPV

Patient Information

The study focused on a cohort of 17 participants suffering from refractory plantar warts (PWs). These patients represented a clinically challenging demographic, as all had previously failed standard-of-care treatments, including topical salicylic acid, cryotherapy, and laser interventions. The persistent nature of their lesions had resulted in significant physical discomfort and psychological distress. On average, the patients presented with multiple lesions (a total of 236 lesions across the 17 participants), indicating a high viral load or significant immune evasion by the human papillomavirus (HPV).

Diagnosis

Diagnosis was established through clinical examination by board-certified dermatologists. Key diagnostic features included the presence of hyperkeratotic papules on the plantar surface of the feet, disruption of normal skin lines (dermatoglyphics), and the presence of ‘seeds’ or thrombosed capillaries observed upon paring of the hyperkeratotic tissue. The refractory nature was confirmed by a documented history of non-responsiveness to at least two different destructive modalities over a period of six months or longer.

Differential Diagnosis

During the diagnostic phase, several conditions were considered and ruled out:

  • Clavus (Corns): Ruled out by the presence of punctate hemorrhages upon debridement and the loss of skin striae, which are characteristic of warts but absent in corns.
  • Callus: Ruled out as the lesions were focal and exhibited the classic cauliflower-like texture of verrucae rather than simple diffuse hyperkeratosis.
  • Verrucous Carcinoma: Although rare, this was considered in cases of extreme recalcitrance; however, the clinical presentation and response to treatment favored a viral etiology.
  • Molluscum Contagiosum: Ruled out due to the specific plantar location and hyperkeratotic morphology.

Treatment and Management

The intervention involved a daily, 30-minute immersion of the affected area in a saturated saline solution. Saturated saline was prepared by dissolving common salt (NaCl) in warm water until no more salt could be dissolved. The protocol was as follows:

  • Preparation: Participants were instructed on how to prepare the saturated solution at home.
  • Immersion: The feet were soaked for 30 minutes every evening for a duration of 8 weeks.
  • Debridement: Gentle removal of softened hyperkeratotic tissue was permitted but not required as a primary mechanical intervention.
  • Monitoring: Patients were monitored for adverse effects such as skin irritation, erosion, or pain. Notably, the treatment was described as painless and noninvasive, a significant departure from destructive methods like liquid nitrogen cryotherapy.

Outcome and Prognosis

The results of the 8-week trial were highly significant. At the lesion level, 98.3% (232 out of 236) of the warts cleared completely. At the participant level, 15 out of 17 (88.2%) achieved complete remission (95% CI 63.3% to 97.4%). All participants who achieved clearance remained lesion-free during a 6-month follow-up period, indicating a lack of short-term recurrence. The prognosis for these previously refractory cases was excellent, with high patient satisfaction due to the lack of treatment-induced pain or scarring.

Discussion

The management of plantar warts remains a therapeutic dilemma. Standard destructive treatments often cause pain and secondary infections, leading to poor patient compliance and high recurrence rates. This trial suggests that saturated saline immersion is a viable, low-cost, and painless alternative. The mechanism of action likely involves the osmotic effect of hypertonic saline, which may induce cellular dehydration in the HPV-infected keratinocytes, potentially disrupting the viral microenvironment and stimulating a local immune response.

Compared to existing literature, which cites success rates for cryotherapy between 50-70% often requiring multiple painful sessions, the 88.2% remission rate observed here is exceptional for a refractory population. The lack of recurrence over six months is particularly noteworthy, as HPV often remains latent in surrounding tissue. However, the study’s single-arm design and small sample size are limitations. Future randomized controlled trials (RCTs) are necessary to compare saline immersion directly against placebo or standard therapies to establish it as a primary clinical guideline.

References

1. Xu Y, Li T, Liang X, et al. Saturated saline immersion for the treatment of refractory plantar warts: An open-label, one-arm, single-center trial. J Am Acad Dermatol. 2026;94(2):525-529. doi:10.1016/j.jaad.2025.10.014.
2. Sterling JC, et al. British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-712.
3. Kwok CS, et al. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;9:CD001781.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Molecular Stratification of Early-Stage Vulvar Squamous Cell Carcinoma: Prognostic Impact of HPV and TP53 StatusThis study highlights how HPV and TP53 molecular subtyping in stage I vulvar squamous cell carcinoma delineates survival outcomes and recurrence risks, supporting its role in personalized management strategies.Sep 19, 2026HPV-Associated Anal Dysplasia in Solid Organ Transplant Recipients: Unraveling Transplant-Specific Mucosal Immune DysfunctionSolid organ transplant recipients have increased risk of HPV-driven anal dysplasia and cancer due to unique immune alterations from immunosuppression. This article explores the transplant-specific immune dysfunction underlying persistent HPSep 5, 2026HPV-Associated Anal Dysplasia in Solid Organ Transplant Recipients: Exploring Transplant-Specific Mucosal Immune DysregulationSolid organ transplant recipients exhibit heightened risk for HPV-associated anal dysplasia and cancer due to unique immunosuppressive alterations. A transplant-tailored model of mucosal immune dysfunction elucidates mechanisms driving persSep 3, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Equivalence of Online and In-Person Care in Managing Atopic Dermatitis: Insights from a Large Randomized Trial
A randomized clinical trial shows online team-based care is as effective as conventional in-person treatment for atopic dermatitis, offering an accessible alternative for chronic disease management.
Aug 27, 2026
A Practical Framework for Pyoderma Gangrenosum: Expert Consensus Defines Phenotypes and ModifiersAn expert Delphi panel established a standardized, descriptive classification for pyoderma gangrenosum (PG) to improve diagnosis, research, and treatment planning by defining distinct phenotypes and key disease modifiers.Aug 12, 2026
Enhancing Triage of Non-16/18 High-Risk HPV Cervical Lesions Using FAM19A4, SOX1, and PAX1 Methylation TestingFAM19A4, SOX1, and PAX1 methylation assays demonstrate high diagnostic accuracy for identifying CIN3+ among non-16/18 hrHPV-positive women, outperforming cytology and reducing unnecessary colposcopies.Aug 18, 2026